BioElectronics Corporation's Chairman Updates Investors
16. Oktober 2024 08:45 ET
|
BioElectronics Corporation
Outlines Sales Activities, Clinical Trials, and a Potential Legal Action Against MundiPharma FREDERICK, Md., Oct. 16, 2024 (GLOBE NEWSWIRE) -- BioElectronics Corporation (https://www.bielcorp.com/...
BioElectronics Founder and CEO Andrew J. Whelan Has Died Suddenly
07. Oktober 2019 12:37 ET
|
BioElectronics Corporation
FREDERICK, MD, Oct. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corp. (OTCPK: BIEL) is sad to announce that its founder and CEO, Andrew J. Whelan, died suddenly last night at his...
Update: BioElectronics Announces Publication of a Study of the ActiPatch Medical Device as an Effective Long-Term Treatment for Chronic Pain
02. Oktober 2019 21:29 ET
|
BioElectronics Corporation
FREDERICK, MD, Oct. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL) www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to...
BioElectronics Announces Publication of a Study of the ActiPatch Medical Device as an Effective Long-Term Treatment for Chronic Pain
02. Oktober 2019 09:44 ET
|
BioElectronics Corporation
FREDERICK, MD, Oct. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL) www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to...
BioElectronics Announces FDA Market Clearance for Its Non-Opioid Postoperative Pain Therapy
01. Juli 2019 08:57 ET
|
BioElectronics Corporation
FREDERICK, MD, July 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to...
BioElectronics Announces Publication of Study Verifying the Effectiveness of Its ActiPatch Medical Device on Chronic Pain
03. Juni 2019 09:31 ET
|
BioElectronics Corporation
FREDERICK, MD, June 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL) www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to...
BioElectronics Announces Withdrawal and Planned Resubmission of 510(k) for General Musculoskeletal Pain
22. Mai 2019 10:43 ET
|
BioElectronics Corporation
FREDERICK, MD, May 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL) www.bielcorp.com, the maker of non-invasive electroceutical devices, announced today...
BioElectronics Announces Back Pain Clinical Study with Leading Australian Pain Center
08. März 2019 10:36 ET
|
BioElectronics Corporation
Pulsed Shortwave Neuromodulation Therapy (ActiPatch®) Study in Chronic Lower Back Pain FREDERICK, MD, March 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC...
BioElectronics Announces FDA Market Clearance Update
27. November 2018 09:31 ET
|
BioElectronics Corporation
FREDERICK, MD, Nov. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC Pink: BIEL), the maker of non-invasive electroceutical devices, announced that the U.S. Food...
BioElectronics Applies for FDA’s Opioid Alternative Innovation Challenge Program
13. August 2018 07:30 ET
|
BioElectronics Corporation
FREDERICK, MD, Aug. 13, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, is pleased to announce that it has submitted an application to the U.S. Food and Drug...